Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Risk Factors Associated with Decreased Renal Function after Hand-Assisted Laparoscopic Donor Nephrectomy: A Multivariate Analysis of a Single Surgeon Experience.

Lim J, Kong YG, Kim YK, Hong B.

Int J Med Sci. 2017 Feb 8;14(2):159-166. doi: 10.7150/ijms.17585. eCollection 2017.

2.

Morbidity and Mortality Rounds in Liver Transplantation.

Kocabayoglu P, Husen M, Witzke O, Kribben A, Saner FH, Canbay A, Gerken G, Paul A.

Visc Med. 2016 Aug;32(4):272-277. Epub 2016 Jul 29. Review.

3.

Estimating the harms and benefits of prostate cancer screening as used in common practice versus recommended good practice: A microsimulation screening analysis.

Carlsson SV, de Carvalho TM, Roobol MJ, Hugosson J, Auvinen A, Kwiatkowski M, Villers A, Zappa M, Nelen V, Páez A, Eastham JA, Lilja H, de Koning HJ, Vickers AJ, Heijnsdijk EA.

Cancer. 2016 Nov 15;122(21):3386-3393. doi: 10.1002/cncr.30192. Epub 2016 Jul 26.

PMID:
27459245
4.

The Value of Continuity between Primary Care and Surgical Care in Colon Cancer.

Hussain T, Chang HY, Luu NP, Pollack CE.

PLoS One. 2016 May 24;11(5):e0155789. doi: 10.1371/journal.pone.0155789. eCollection 2016.

5.

Effect of radical prostatectomy surgeon volume on complication rates from a large population-based cohort.

Almatar A, Wallis CJ, Herschorn S, Saskin R, Kulkarni GS, Kodama RT, Nam RK.

Can Urol Assoc J. 2016 Jan-Feb;10(1-2):45-9. doi: 10.5489/cuaj.3214.

6.

Prospective evaluation of complications in laparoscopic urology at a mid-volume institution using standardized criteria: Experience of 1023 cases including learning curve in 9 years.

Sanli O, Tefik T, Erdem S, Ortac M, Salabas E, Karakus S, Yucel B, Boyuk A, Oktar T, Ozcan F, Aras N, Tunc M, Nane I.

J Minim Access Surg. 2016 Jan-Mar;12(1):33-40. doi: 10.4103/0972-9941.158154.

7.

Defining the value framework for prostate brachytherapy using patient-centered outcome metrics and time-driven activity-based costing.

Thaker NG, Pugh TJ, Mahmood U, Choi S, Spinks TE, Martin NE, Sio TT, Kudchadker RJ, Kaplan RS, Kuban DA, Swanson DA, Orio PF, Zelefsky MJ, Cox BW, Potters L, Buchholz TA, Feeley TW, Frank SJ.

Brachytherapy. 2016 May-Jun;15(3):274-82. doi: 10.1016/j.brachy.2016.01.003. Epub 2016 Feb 23.

8.

Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy.

Boero IJ, Paravati AJ, Xu B, Cohen EE, Mell LK, Le QT, Murphy JD.

J Clin Oncol. 2016 Mar 1;34(7):684-90. doi: 10.1200/JCO.2015.63.9898. Epub 2016 Jan 4.

9.

Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage.

Pfister DG, Rubin DM, Elkin EB, Neill US, Duck E, Radzyner M, Bach PB.

JAMA Oncol. 2015 Dec;1(9):1303-10. doi: 10.1001/jamaoncol.2015.3151. Erratum in: JAMA Oncol. 2015 Dec;1(9):1323.

10.

Observations on Surgeons' Case Selection, Morbidity, and Mortality Following Board Certification.

Guidry CA, Newhook TE, Turrentine FE, Sohn MW, Sawyer RG, Jones RS.

Ann Surg. 2016 Mar;263(3):487-92. doi: 10.1097/SLA.0000000000001361.

11.

Post-prostatectomy incontinence: Etiology, evaluation, and management.

Singla N, Singla AK.

Turk J Urol. 2014 Mar;40(1):1-8. doi: 10.5152/tud.2014.222014. Review.

12.

Influence of treatment center and hospital volume on survival for locally advanced cervical cancer.

Wright JD, Huang Y, Ananth CV, Tergas AI, Duffy C, Deutsch I, Burke WM, Hou JY, Neugut AI, Hershman DL.

Gynecol Oncol. 2015 Dec;139(3):506-12. doi: 10.1016/j.ygyno.2015.07.015. Epub 2015 Jul 12.

13.

Regional Cost Variations of Robot-Assisted Radical Prostatectomy Compared With Open Radical Prostatectomy.

Faiena I, Dombrovskiy VY, Modi PK, Patel N, Patel R, Salmasi AH, Parihar JS, Singer EA, Kim IY.

Clin Genitourin Cancer. 2015 Oct;13(5):447-52. doi: 10.1016/j.clgc.2015.05.004. Epub 2015 May 28.

14.

Fragmentation in specialist care and stage III colon cancer.

Hussain T, Chang HY, Veenstra CM, Pollack CE.

Cancer. 2015 Sep 15;121(18):3316-24. doi: 10.1002/cncr.29474. Epub 2015 Jun 4.

15.

Collaboration Between Surgeons and Medical Oncologists and Outcomes for Patients With Stage III Colon Cancer.

Hussain T, Chang HY, Veenstra CM, Pollack CE.

J Oncol Pract. 2015 May;11(3):e388-97. doi: 10.1200/JOP.2014.003293. Epub 2015 Apr 14.

16.

Evaluation and Management of the Geriatric Urologic Oncology Patient.

McKibben MJ, Smith AB.

Curr Geriatr Rep. 2015 Mar;4(1):7-15.

17.

Relationship between surgical oncologic outcomes and publically reported hospital quality and satisfaction measures.

Wright JD, Tergas AI, Ananth CV, Burke WM, Chen L, Neugut AI, Richards CA, Hershman DL.

J Natl Cancer Inst. 2015 Jan 24;107(3). pii: dju409. doi: 10.1093/jnci/dju409. Print 2015 Mar.

18.

Policy guidelines suggested for robot-assisted prostatectomy.

Valvo JR, Madeb R, Gilbert R, Nicholson C, Oleyourryk G, Perrapato S, Ricottone A, Roberts W, Eichel L.

J Robot Surg. 2007;1(3):173-6. doi: 10.1007/s11701-007-0031-0. Epub 2007 Jul 31. No abstract available.

19.

Technology diffusion and prostate cancer quality of care.

Schroeck FR, Kaufman SR, Jacobs BL, Skolarus TA, Zhang Y, Hollenbeck BK.

Urology. 2014 Nov;84(5):1066-72. doi: 10.1016/j.urology.2014.06.067. Epub 2014 Oct 24.

20.

The impact of fellowship training on pathological outcomes following radical prostatectomy: a population based analysis.

Nayak JG, Drachenberg DE, Mau E, Suderman D, Bucher O, Lambert P, Quon H.

BMC Urol. 2014 Oct 23;14:82. doi: 10.1186/1471-2490-14-82.

Supplemental Content

Support Center